Cite
HARVARD Citation
Volkmann, E. et al. (2016). Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease. Arthritis research & therapy. 18 (1), pp. 1-9. [Online].